Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
in molecular biology or related fields Practical experience with genomics and bioinformatics methods A solid knowledge of single cell omics technologies and data analysis A strong research record
-
if the candidate has gained solid experience in relevant omics analyses (esp. Single-cell methodologies and/or multi-omics). Experience in live cell image analysis, and/or metabolic analyses is a plus, as we also
-
genetics, gene therapy, CRISPR-based gene editing, stem cell technologies, and translational disease modelling. We are particularly interested in developing treatments for retinal disorders prevalent in
-
regenerative capacity of liver tissue. Your work will involve the use of research animals to investigate cell-cell interactions during regenerative processes and to developed new in vitro organoid models. You
-
system Caenorhabditis elegans together with mammalian cell systems to study how RNAs with expanded nucleotide repeats cause broad cellular energy metabolism disruptions. The project focuses on identifying
-
/ Bioinformatician to join our collaborative, multidisciplinary research team applying single-cell methodologies to study treatment resistance in ovarian cancer. Vähärautio lab (https://vaharautiolab.org
-
effects in endometriosis into a structured, openly available knowledge base using systematic evidence mapping and language model-assisted approaches Establishing human endometrial cell models and carrying
-
regulation, with the long-term goal of enabling more precise design of RNA therapeutics for complex diseases. The doctoral researcher will analyse large-scale single-cell and bulk multi-omics datasets
-
to more than one; state your preference in your motivation letter. 1. Neurodevelopmental proteomics You will map the molecular circuitry of human neurodevelopment using advanced 2D and 3D cell models together
-
of radiolabeling precursors, radiolabeling synthesis development, radiolabeled compound characterization and biological evaluation of the developed ligands in vitro in cell models and in vivo in mouse tumor models